Precision BioSciences (DTIL)
(Delayed Data from NSDQ)
$13.56 USD
+0.58 (4.47%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $13.55 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
Cash flow Statements
Fiscal Year End for Precision BioSciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -111.64 | -30.60 | -109.01 | -92.88 |
Depreciation/Amortization & Depletion | NA | 8.65 | 10.18 | 9.81 | 5.32 |
Net Change from Assets/Liabilities | NA | 24.11 | 19.58 | -2.01 | -2.36 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 33.13 | -10.02 | 13.82 | 18.90 |
Net Cash From Operating Activities | NA | -45.75 | -10.85 | -87.39 | -71.02 |
Property & Equipment | NA | -3.32 | -5.05 | -5.03 | -24.67 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | -0.75 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -3.32 | -5.80 | -5.03 | -24.67 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 75.18 | 68.06 | 1.33 | 136.45 |
Issuance (Repayment) of Debt | NA | 0.00 | -2.51 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 19.81 | 4.97 | 0.00 | 39.55 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | -2.62 |
Net Cash from Financing Activities | NA | 94.99 | 70.52 | 1.33 | 173.37 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 45.91 | 53.87 | -91.09 | 77.69 |
Cash at Beginning of Period | NA | 143.66 | 89.80 | 180.89 | 103.19 |
Cash at End of Period | NA | 189.58 | 143.66 | 89.80 | 180.89 |
Diluted Net EPS | NA | -38.14 | -15.62 | -62.76 | -66.37 |
Fiscal Year End for Precision BioSciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -45.03 | -36.95 | -25.06 | -111.64 |
Depreciation/Amortization & Depletion | NA | 6.39 | 4.47 | 2.18 | 8.65 |
Net Change from Assets/Liabilities | NA | -44.44 | -31.76 | -15.01 | 24.11 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 7.40 | 11.64 | 6.42 | 33.13 |
Net Cash From Operating Activities | NA | -75.69 | -52.60 | -31.46 | -45.75 |
Property & Equipment | NA | -1.91 | -1.53 | -0.52 | -3.32 |
Acquisition/ Disposition of Subsidiaries | NA | 8.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | -0.30 | -0.25 | -0.20 | 0.00 |
Net Cash from Investing Activities | NA | 5.79 | -1.78 | -0.72 | -3.32 |
Uses of Funds
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 2.56 | 2.59 | 0.74 | 75.18 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 19.81 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 2.56 | 2.59 | 0.74 | 94.99 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -67.35 | -51.78 | -31.44 | 45.91 |
Cash at Beginning of Period | NA | 189.58 | 189.58 | 189.58 | 143.66 |
Cash at End of Period | NA | 122.23 | 137.79 | 158.13 | 189.58 |
Diluted Net EPS | NA | -2.10 | -3.00 | -6.91 | -3.90 |